Pharmacological and neurochemical characterization of the involvement of hippocampal adrenoreceptor subtypes in the modulation of acute limbic seizures

Journal of Neurochemistry

Volumn 115, Issue 6, 2010, Pages 1595-1607

  Clinckers, Ralph ^a   Zgavc, Tine ^a   Vermoesen, Katia ^a   Meurs, Alfred ^a   Michotte, Yvette ^a   Smolders, Ilse ^a  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

epilepsy; hippocampus; microdialysis; noradrenaline

Indexed keywords

1,3,4,5',6,6',7,12B OCTAHYDRO 1',3' DIMETHYL 2H SPIRO[BENZO[B]FURO[2,3 A]QUINOLIZINE 2,4' PYRIMIDINE] 2' ONE; 2 (1 METHYL 2 ISOINDOLINYLMETHYL) 2 IMIDAZOLINE; 3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; 6 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 1H 3 BENZAZEPINE; 8 [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] 8 AZASPIRO[4.5]DECANE 7,9 DIONE; ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; DOPAMINE; MAPROTILINE; MEDETOMIDINE; N [5 (4,5 DIHYDRO 1H IMIDAZOL 2 YL) 5,6,7,8 TETRAHYDRO 2 HYDROXY 1 NAPHTHYL]METHANESULFONAMIDE; NORADRENALIN; PILOCARPINE; SALMETEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; COMPLEX PARTIAL SEIZURE; CONTROLLED STUDY; DOPAMINE BLOOD LEVEL; DRUG EFFICACY; DRUG SELECTIVITY; HIPPOCAMPUS; MALE; NERVE EXCITABILITY; NEUROTRANSMISSION; NONHUMAN; NORADRENALIN BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; RECEPTOR BLOCKING; TREATMENT RESPONSE;

ADRENERGIC AGONISTS; ADRENERGIC ANTAGONISTS; ANIMALS; HIPPOCAMPUS; LIMBIC SYSTEM; MALE; PROTEIN SUBUNITS; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC; RECEPTORS, ADRENERGIC, ALPHA-1; RECEPTORS, ADRENERGIC, ALPHA-2; RECEPTORS, ADRENERGIC, BETA-2; SEIZURES;

EID: 78649997919     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2010.07065.x     Document Type: Article

References (64)

1. Ago J., Ishikawa T., Matsumoto N., Ashequr Rahman M., and, Kamei C., (2006) Mechanism of imipramine-induced seizures in amygdala-kindled rats. Epilepsy Res. 72, 1-9.
2. Ago J., Ishikawa T., Matsumoto N., Rahman M. A., and, Kamei C., (2007) Epileptiformic activity induced by antidepressants in amygdala-kindled rats. Eur. J. Pharmacol. 560, 23-28.
3. Alam A. M., and, Starr M. S., (1992) Dopaminergic modulation of pilocarpine-induced motor seizures in the rat: the role of hippocampal dopamine D1 receptors. Eur. J. Pharmacol. 222, 227-232.
4. Alam A. M., and, Starr M. S., (1993) Dopaminergic modulation of pilocarpine-induced motor seizures in the rat: the role of hippocampal D2 receptors. Neuroscience 53, 425-431.
5. Arai S., Morita K., Kitayama S., Kumagai K., Kumagai M., Kihira K., and, Dohi T., (2003) Chronic inhibition of the norepinephrine transporter in the brain participates in seizure sensitization to cocaine and local anesthetics. Brain Res. 964, 83-90.
6. Aubert M., Guiramand J., Croce A., Roch G., Szafarczyk A., and, Vignes M., (2001) An endogenous adrenoceptor ligand potentiates excitatory synaptic transmission in cultured hippocampal neurons. Cereb. Cortex 11, 878-887.
7. Benveniste H., and, Huttemeier P. C., (1990) Microdialysis-theory and application. Prog. Neurobiol. 35, 195-215.
8. Benveniste H., Drejer J., Schousboe A., and, Diemer N. H., (1984) Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J. Neurochem. 43, 1369-1374.
9. Bergles D. E., Doze V. A., Madison D. V., and, Smith S. J., (1996) Excitatory actions of norepinephrine on multiple classes of hippocampal CA1 interneurons. J. Neurosci. 16, 572-585.
10. Bischoff S., Scatton B., and, Korf J., (1979) Biochemical evidence for a transmitter role of dopamine in the rat hippocampus. Brain Res. 165, 161-165.
11. Clapp-Lilly K. L., Roberts R. C., Duffy L. K., Irons K. P., Hu Y., and, Drew K. L., (1999) An ultrastructural analysis of tissue surrounding a microdialysis probe. J. Neurosci. Methods 90, 129-142.
12. Clifford D. B., Rutherford J. L., Hicks F. G., and, Zorumski C. F., (1985) Acute effects of antidepressants on hippocampal seizures. Ann. Neurol. 18, 692-697.
13. Clinckers R., Smolders I., Meurs A., Ebinger G., and, Michotte Y., (2004a) Anticonvulsant action of GBR-12909 and citalopram against acute experimentally induced limbic seizures. Neuropharmacology 47, 1053-1061.
14. Clinckers R., Smolders I., Meurs A., Ebinger G., and, Michotte Y., (2004b) Anticonvulsant action of hippocampal dopamine and serotonin is independently mediated by D2 and 5-HT1A receptors. J. Neurochem. 89, 834-843.
15. Clinckers R., Gheuens S., Smolders I., Meurs A., Ebinger G., and, Michotte Y., (2005) In vivo modulatory action of extracellular glutamate on the anticonvulsant effects of hippocampal dopamine and serotonin. Epilepsia 46, 828-836.
16. Dailey J. W., and, Naritoku D. K., (1996) Antidepressants and seizures: clinical anecdotes overshadow neuroscience. Biochem. Pharmacol. 52, 1323-1329.
17. Day H. E., Campeau S., Watson S. J., and, Akil H., (1997) Distribution of alpha 1a-, alpha 1b- and alpha 1d-adrenergic receptor mRNA in the rat brain and spinal cord. J. Chem. Neuroanat. 13, 115-139.
18. Del Arco A., Segovia G., Fuxe K., and, Mora F., (2003) Changes in dialysate concentrations of glutamate and GABA in the brain: an index of volume transmission mediated actions? J. Neurochem. 85, 23-33.
19. Fischer W., (2002) Anticonvulsant profile and mechanism of action of propranolol and its two enantiomers. Seizure 11, 285-302.
20. Fischer W., Kittner H., Regenthal R., Malinowska B., and, Schlicker E., (2001) Anticonvulsant and sodium channel blocking activity of higher doses of clenbuterol. Naunyn Schmiedebergs Arch. Pharmacol. 363, 182-192.
21. Gereau R. W., and, Conn P. J., (1994) Presynaptic enhancement of excitatory synaptic transmission by beta-adrenergic receptor activation. J. Neurophysiol. 72, 1438-1442.
22. Giorgi F. S., Pizzanelli C., Biagioni F., Murri L., and, Fornai F., (2004) The role of norepinephrine in epilepsy: from the bench to the bedside. Neurosci. Biobehav. Rev. 28, 507-524.
23. Giros B., Wang Y. M., Suter S., McLeskey S. B., Pifl C., and, Caron M. G., (1994) Delineation of discrete domains for substrate, cocaine, and tricyclic antidepressant interactions using chimeric dopamine-norepinephrine transporters. J. Biol. Chem. 269, 15985-15988.
24. Gobert A., and, Millan M. J., (1999) Modulation of dialysate levels of dopamine, noradrenaline, and serotonin (5-HT) in the frontal cortex of freely-moving rats by (-)-pindolol alone and in association with 5-HT reuptake inhibitors: comparative roles of beta-adrenergic, 5-HT1A, and 5-HT1B receptors. Neuropsychopharmacology 21, 268-284.
25. Guiard B. P., El Mansari M., and, Blier P., (2008) Cross-talk between dopaminergic and noradrenergic systems in the rat ventral tegmental area, locus ceruleus, and dorsal hippocampus. Mol. Pharmacol. 74, 1463-1475.
26. Harley C. W., (2007) Norepinephrine and the dentate gyrus. Prog. Brain Res. 163, 299-318.
27. Hieble J. P., (2007) Subclassification and nomenclature of alpha- and beta-adrenoceptors. Curr. Top. Med. Chem. 7, 129-134.
28. Hillman K. L., Doze V. A., and, Porter J. E., (2005) Functional characterization of the beta-adrenergic receptor subtypes expressed by CA1 pyramidal cells in the rat hippocampus. J. Pharmacol. Exp. Ther. 314, 561-567.
29. Hillman K. L., Doze V. A., and, Porter J. E., (2007) Alpha1A-adrenergic receptors are functionally expressed by a subpopulation of cornu ammonis 1 interneurons in rat hippocampus. J. Pharmacol. Exp. Ther. 321, 1062-1068.
30. Hillman K. L., Lei S., Doze V. A., and, Porter J. E., (2009) Alpha-1A adrenergic receptor activation increases inhibitory tone in CA1 hippocampus. Epilepsy Res. 84, 97-109.
31. Jobe P. C., and, Browning R. A., (2005) The serotonergic and noradrenergic effects of antidepressant drugs are anticonvulsant, not proconvulsant. Epilepsy Behav. 7, 602-619.
32. Jurgens C. W., Boese S. J., King J. D., Pyle S. J., Porter J. E., and, Doze V. A., (2005) Adrenergic receptor modulation of hippocampal CA3 network activity. Epilepsy Res. 66, 117-128.
33. Jurgens C. W., Hammad H. M., Lichter J. A., et al. (2007) Alpha2A adrenergic receptor activation inhibits epileptiform activity in the rat hippocampal CA3 region. Mol. Pharmacol. 71, 1572-1581.
34. Kanner A. M., (2008) Depression in epilepsy: a complex relation with unexpected consequences. Curr. Opin. Neurol. 21, 190-194.
35. Kanner A. M., and, Balabanov A., (2002) Depression and epilepsy: how closely related are they? Neurology 58, S27-S39.
36. Katzung B. G., Masters S. B., and, Trevor A. J., eds (2009) Basic and Clinical Pharmacology. MCGraw-Hill Companies Inc., London.
37. LaFrance W. C., Jr, Kanner A. M., and, Hermann B., (2008) Psychiatric comorbidities in epilepsy. Int. Rev. Neurobiol. 83, 347-383.
38. Loy R., Koziell D. A., Lindsey J. D., and, Moore R. Y., (1980) Noradrenergic innervation of the adult rat hippocampal formation. J. Comp. Neurol. 189, 699-710.
39. Meurs A., Clinckers R., Ebinger G., Michotte Y., and, Smolders I., (2008) Seizure activity and changes in hippocampal extracellular glutamate, GABA, dopamine and serotonin. Epilepsy Res. 78, 50-59.
40. Millan M. J., (2006) Multi-target strategies for the improved treatment of depressive states: conceptual foundations and neuronal substrates, drug discovery and therapeutic application. Pharmacol. Ther. 110, 135-370.
41. Millan M. H., Chapman A. G., and, Meldrum B. S., (1993) Extracellular amino acid levels in hippocampus during pilocarpine-induced seizures. Epilepsy Res. 14, 139-148.
42. Murugaiah K. D., and, O'Donnell J. M., (1995) Facilitation of noradrenaline release from rat brain slices by beta-adrenoceptors. Naunyn Schmiedebergs Arch. Pharmacol. 351, 483-490.
43. O'Donnell J. M., (1997) Pharmacological characterization of the discriminative stimulus effects of clenbuterol in rats. Pharmacol. Biochem. Behav. 58, 813-818.
44. Parpura V., and, Haydon P. G., (2000) Physiological astrocytic calcium levels stimulate glutamate release to modulate adjacent neurons. Proc. Natl Acad. Sci. USA 97, 8629-8634.
45. Paxinos G., and, Watson C., (1997) The Rat Brain in Stereotaxic Coordinates. Academic Press, San Diego.
46. Pupo A. S., and, Minneman K. P., (2001) Adrenergic pharmacology: focus on the central nervous system. CNS Spectr. 6, 656-662.
47. Racine R. J., (1972) Modification of seizure activity by electrical stimulation II. Motor seizure. Electroencephalogr. Clin. Neurophysiol. 32, 281-294.
48. Richelson E., and, Nelson A., (1984) Antagonism by neuroleptics of neurotransmitter receptors of normal human brain in vitro. Eur. J. Pharmacol. 103, 197-204. (Pubitemid 14028974)
49. Richter D. W., Schmidt-Garcon P., Pierrefiche O., Bischoff A. M., and, Lalley P. M., (1999) Neurotransmitters and neuromodulators controlling the hypoxic respiratory response in anaesthetized cats. J. Physiol. 514, 567-578.
50. Ruffmann C., Bogliun G., and, Beghi E., (2006) Epileptogenic drugs: a systematic review. Expert Rev. Neurother. 6, 575-589.
51. Sarre S., Thorre K., Smolders I., and, Michotte Y., (1997) Microbore liquid chromatography analysis of monoamine transmitters. Methods Mol. Biol. 72, 185-196.
52. Scanziani M., Gahwiler B. H., and, Thompson S. M., (1993) Presynaptic inhibition of excitatory synaptic transmission mediated by alpha adrenergic receptors in area CA3 of the rat hippocampus in vitro. J. Neurosci. 13, 5393-5401.
53. Schmidt D., (2009) Drug treatment of epilepsy: options and limitations. Epilepsy Behav. 15, 56-65.
54. Smolders I., Sarre S., Michotte Y., and, Ebinger G., (1995) The analysis of excitatory, inhibitory and other amino acids in rat brain microdialysates using microbore liquid chromatography. J. Neurosci. Methods 57, 47-53.
55. Smolders I., Sarre S., Ebinger G., and, Michotte Y., (1997) Microbore liquid chromatography analysis of amino acid transmitters. Methods Mol. Biol. 72, 197-204.
56. Smolders I., Lindekens H., Clinckers R., Meurs A., O'Neill M. J., Lodge D., Ebinger G., and, Michotte Y., (2004) In vivo modulation of extracellular hippocampal glutamate and GABA levels and limbic seizures by group I and II metabotropic glutamate receptor ligands. J. Neurochem. 88, 1068-1077.
57. Szot P., Lester M., Laughlin M. L., Palmiter R. D., Liles L. C., and, Weinshenker D., (2004) The anticonvulsant and proconvulsant effects of alpha2-adrenoreceptor agonists are mediated by distinct populations of alpha2A-adrenoreceptors. Neuroscience 126, 795-803.
58. Van Hemelrijck A., Sarre S., Smolders I., and, Michotte Y., (2005) Determination of amino acids associated with cerebral ischaemia in rat brain microdialysates using narrowbore liquid chromatography and fluorescence detection. J. Neurosci. Methods 144, 63-71.
59. Vizi E. S., and, Kiss J. P., (1998) Neurochemistry and pharmacology of the major hippocampal transmitter systems: synaptic and nonsynaptic interactions. Hippocampus 8, 566-607.
60. Warter J. M., Tranchant C., Marescaux C., Depaulis A., Lannes B., and, Vergnes M., (1990) Immediate effects of 14 non MAOI antidepressants in rats with spontaneous petit mal-like seizures. Prog. Neuropsychopharmacol. Biol. Psychiatry 14, 261-270.
61. Weinshenker D., and, Szot P., (2002) The role of catecholamines in seizure susceptibility: new results using genetically engineered mice. Pharmacol. Ther. 94, 213-233.
62. Winzer-Serhan U. H., and, Leslie F. M., (1997) Alpha2B adrenoceptor mRNA expression during rat brain development. Brain Res. Dev. Brain Res. 100, 90-100.
63. Winzer-Serhan U. H., Raymon H. K., Broide R. S., Chen Y., and, Leslie F. M., (1997a) Expression of alpha 2 adrenoceptors during rat brain development-I Alpha 2A messenger RNA expression. Neuroscience 76, 241-260.
64. Winzer-Serhan U. H., Raymon H. K., Broide R. S., Chen Y., and, Leslie F. M., (1997b) Expression of alpha 2 adrenoceptors during rat brain development-II Alpha 2C messenger RNA expression and [3H]rauwolscine binding. Neuroscience 76, 261-272. (Pubitemid 26407953)